NSAIDs Raise Death Risk post-MI
Gunnar Gislason
As the dust continues to settle on the Vioxx issue, there is naturally a desire to look further at potential cardiovascular risks associated with COX-2 inhibitors and, indeed, other non-steroidal anti-inflammatories. Gunnar Gislason from Bispebjerg University Hospital has been leading a study aiming to look throughout Denmark for a relationship between the use of these drugs and mortality in people who have had a myocardial infarction.
[audio:https://www.audiomedica.com/podcasting/aha2005/Gunnar_Gislason.mp3]
